Study reveals IL-22BP protein’s role in gut health and infection resistance

FHS
July 30, 2024
3:12 am

A study reported in Proceedings of the National Academy of Sciences (PNAS) shows how the presence of a specific protein called IL-22BP affects the composition of the gut microbiota and the body’s response to bacterial infection.

23andMe board rejects CEO Wojcicki’s take-private proposal

A special committee of 23andMe’s board of directors said Friday it was “disappointed” in a proposal by CEO Anne Wojcicki to take the company private.

August 2, 2024

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach – Biotech Investments

EQS-News: Pentixapharm Holding AG / Key word(s): Study First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding

November 22, 2024

New study reveals increased risk of allergic diseases after COVID-19 infection

The association of COVID-19 with long term allergic conditions.

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.